Press Release

Jan, 12 2024

Exploring Egypt's Syringes, Auto Disable Syringe, and IV Cannulas Market: Trends, Growth, and Healthcare Impact

The Egypt syringes, auto disabled syringe, and IV cannulas market is a dynamic healthcare sector characterized by increasing demand for safety and quality. Auto-disable syringes, designed to prevent reuse, have gained prominence due to their role in preventing disease transmission. IV cannulas, used for intravenous therapy, also show growth potential. These trends are creating opportunities for both local and international manufacturers in Egypt's syringes, auto-disable syringes, and IV cannulas market.

Access Full Report @ https://www.databridgemarketresearch.com/jp/reports/egypt-syringes-auto-disable-syringe-and-iv-cannulas-market

Data Bridge Market Research analyses that the Egypt Syringes, Auto Disabled Syringe, and IV Cannulas Market is expected to grow at a CAGR of 5.10% in the forecast period of 2023 to 2030 and is expected to reach USD 79.81million by 2030 from USD 53.61 million in 2022. Egypt's expanding population is driving up the need for healthcare services and associated medical equipment such as syringes and IV cannulas. As more people require medical care, the demand for these essential tools is rising, contributing to the growth of the healthcare device market in the country.

Key Findings of the Stud

Egypt Syringes, Auto Disable Syringe and IV Cannulas Market

Technological advancements are expected to drive the market's growth rate

Technological advancements in syringe and IV cannula design have led to significant product innovations in Egypt's medical device market. These innovations include safety mechanisms, precision engineering for accurate drug delivery, and materials for patient comfort. These improvements enhance the effectiveness and safety of medical procedures, driving market growth as healthcare providers seek more advanced and reliable tools, ultimately improving patient care and outcomes.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (General Syringes, Specialized Syringes, Smart Syringes), Usage (Reusable Syringes, Disposable Syringes), Type (Auto-Disable Syringes, IV Cannula), Material (Polypropylene Barrel, Rubber Plunger, Lubricant – Silicone Oil), Lock System (Barrel Seal Lock System, Top Plunger Lock System), Volume (0.05ML, 0.1ML, 0.3ML, 0.5ML, 1ML, Others), Gauge Size (14G TO 16G, 17G TO 20G, 22G TO 26G), IV Therapy (Central IV Cannula, Midline IV Cannula, Peripheral IV Cannula), Indication (Vaccines, Infectious Diseases, Inflammatory and Auto-Immune Diseases, Others), Application (Blood Collection, Vaccination, Drug Delivery, Others), End User (Hospitals, Clinics, Research Laboratories, Ambulatory Centers, Others), Distribution Channel (Pharmacies, Specialty Stores, Online, Others)

Market Players Covered

B.D. (U.S.), American Equipment Company, Inc (U.S.), Polymedicure (India), Intermedica, Inc. (Poland), Denex International (India), Ultramedumic (Canada).

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The Egypt syringes, auto disable syringe and IV cannulas market is segmented on the basis of type, usage, IV therapy, material, lock system, volume, gauge size, indication, application, end user, and distribution channel.

  • On the basis of type, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into general syringes, specialized syringes, and smart syringes
  • On the basis of usage, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into reusable syringes, and disposable syringes
  • On the basis of IV therapy, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into central IV cannula, midline IV cannula, and peripheral IV cannula
  • On the basis of material, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into polypropylene barrel, rubber plunger, and lubricant – silicone oil
  • On the basis of lock system, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into Barrel seal lock system, and top plunger lock system
  • On the basis of Volume, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into 0.05ML, 0.1ML, 0.3ML, 0.5ML, 1ML, and others
  • On the basis of gauge size, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into 14G TO 16G, 17G TO 20G, and 22G TO 26G
  • On the basis of indication, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into vaccines, infectious diseases, inflammatory and auto-immune diseases, others
  • On the basis of application, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into blood collection, vaccination, drug delivery, and others
  • On the basis of end user, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into hospitals, clinics, research laboratories, ambulatory centers, others
  • On the basis of distribution channel, the Egypt syringes, auto disable syringe and IV cannulas market is segmented into pharmacies, specialty stores, online, and others

Major Players

Data Bridge Market Research recognizes the following companies as the major Egypt syringes, auto disable syringe and IV cannulas market players in Egypt syringes, auto disable syringe and IV cannulas market are B.D. (U.S.), American Equipment Company, Inc (U.S.), Polymedicure (India), Intermedica, Inc. (Poland), Denex International (India), Ultramedumic (Canada).

Egypt Syringes, Auto Disabled Syringe, and IV Cannulas Market

Market Developments

  • In January 2021, BD, a syringe manufacturer, secured a contract with the U.S. government to provide 286 million syringes, including 40 million low-dead space syringes, for COVID-19 vaccine distribution. This strategic collaboration enhances BD's supply chain capabilities, ensuring efficient vaccine delivery in the market
  • In August 2020, Becton, Dickinson, and Company (BD) announced the acquisition of C. R. Bard, a medical technology firm, for USD 24 billion. This strategic move aimed to strengthen BD's position in the healthcare industry by expanding its product portfolio, particularly in areas such as oncology and surgery, and fostering innovation for enhanced patient care
  • In August 2020, Smith Medical, a leading manufacturer of medical devices, acquired Syringe Co., a prominent producer of syringes and IV cannulas. This strategic move aimed to expand Smith Medical's product portfolio and strengthen its presence in the syringes, auto disable syringe, and IV cannulas market, fostering innovation and growth

For more detailed information about the Egypt syringes, auto disable syringe and IV cannulas market report, click here – https://www.databridgemarketresearch.com/jp/reports/egypt-syringes-auto-disable-syringe-and-iv-cannulas-market


Client Testimonials